Mirae Asset Global ETFs Holdings’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.5K Buy
1,482
+34
+2% +$700 ﹤0.01% 3015
2025
Q4
$33.8K Buy
1,448
+44
+3% +$1.14K ﹤0.01% 3004
2025
Q3
$44.5K Sell
1,404
-253
-15% -$7.64K ﹤0.01% 2969
2025
Q2
$47K Sell
1,657
-725
-30% -$21.7K ﹤0.01% 2893
2025
Q1
$73.5K Buy
2,382
+78
+3% +$2.65K ﹤0.01% 2750
2024
Q4
$76.5K Buy
2,304
+76
+3% +$2.58K ﹤0.01% 2807
2024
Q3
$67.4K Buy
2,228
+601
+37% +$18.7K ﹤0.01% 2853
2024
Q2
$45.9K Buy
+1,627
New +$51.1K ﹤0.01% 2806

Other funds holding SMTI

Mirae Asset Global ETFs Holdings's SMTI Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Sanara MedTech (SMTI) stake by 2.3% in Q1 2026, buying an estimated $700 and bringing the position to 1,482 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3015.

Mirae Asset Global ETFs Holdings first reported a position in SMTI in Q2 2024 and has held it in 8 quarters since. The position peaked at $76.5K in Q4 2024. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 1,482 shares of Sanara MedTech worth $25.5K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 34 Sanara MedTech shares in Q1 2026, an estimated $700.
  • Sanara MedTech made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #3015 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Sanara MedTech in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Sanara MedTech position peaked at $76.5K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.